text: Post Acute Sequelae of SARS CoV 2 Infection Among Adults Aged 18 Years Long Beach California April 1 December 10 2020 Post acute sequelae of COVID 19 also known as long COVID is used to describe the long term symptoms that might be experienced weeks to months after primary infection with SARS CoV 2 the virus that causes COVID 19 Among persons with a previous COVID 19 diagnosis estimates of the prevalence of sequelae range from 5 among nonhospitalized persons to 80 among hospitalized persons 1 2 Studies have analyzed the aftereffects of COVID 19 but few have assessed the demographic characteristics associated with long COVID 3 4 Health disparities resulting from pervasive structural and socioeconomic barriers in the U S health care system might contribute to differences in these effects and might continue to exacerbate existing inequities 5 To identify trends in post acute sequelae the Long Beach Department of Health and Human Services LBDHHS interviewed a random sample of 366 persons aged 18 years who received a positive SARS CoV 2 test result during April 1 December 10 2020 One third of the persons interviewed reported having at least one symptom 2 months after their positive test result with higher odds of sequelae among persons aged 40 54 years females and those with preexisting conditions Black or African American Black participants had higher odds of reporting dyspnea and myalgia arthralgia compared with other racial ethnic groups Persons who were aged 40 years female Black or who reported known preexisting conditions also reported higher numbers of distinct sequelae As the number of recovered COVID 19 patients increases monitoring the prevalence of post acute sequelae among larger cohorts in diverse populations will be necessary to understand and manage this condition Identification of groups disproportionately affected by post acute COVID 19 sequelae can help develop efforts to prioritize preventions and treatment strategies including vaccination of groups at higher risk for these long term sequelae and access to testing and care for post acute sequelae 